| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 31 |
| 1 | METHOTREXATE | 24 |
| 2 | ADALIMUMAB | 18 |
| 3 | ADALIMUMAB-AATY | 17 |
| 4 | ADALIMUMAB-ADAZ | 17 |
| 5 | ADALIMUMAB-FKJP | 17 |
| 6 | CYCLOPHOSPHAMIDE | 13 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 13 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 13 |
| 9 | DOXORUBICIN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DUVELISIB | 2 | 0.0023 |
| 1 | ETOPOSIDE PHOSPHATE | 2 | 0.0012 |
| 2 | FINGOLIMOD HYDROCHLORIDE | 3 | 0.0006 |
| 3 | ADALIMUMAB-FKJP | 17 | 0.0004 |
| 4 | ADALIMUMAB-AATY | 17 | 0.0003 |
| 5 | ADALIMUMAB-ADAZ | 17 | 0.0003 |
| 6 | MYCOPHENILIC ACID | 5 | 0.0002 |
| 7 | MYCOPHENOLIC ACID | 5 | 0.0002 |
| 8 | DOXORUBICIN | 13 | 0.0001 |
| 9 | METHYLPREDNISOLONE ACETATE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antimetabolite Immunosuppressant [EPC] | 5 | 0.0002 |
| 1 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 3 | 0.0002 |
| 2 | Antirheumatic Agent [EPC] | 11 | 0.0001 |
| 3 | Aminosalicylate [EPC] | 9 | 0.0001 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 24 | 0.0001 |
| 5 | Alkylating Drug [EPC] | 13 | 0.0001 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 10 | 0.0000 |
| 7 | Interleukin-12 Antagonist [EPC] | 3 | 0.0000 |
| 8 | Interleukin-23 Antagonist [EPC] | 3 | 0.0000 |
| 9 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |